Stocks of Olink Holding AB (publ) ADR (NASDAQ:OLK) traded higher last session on Wall Street, up 0.19% to $25.83.
According to the data, Olink Holding AB (publ) ADR (NASDAQ:OLK) has 4 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $26.00 and a low of $26.00, we find $26.00. Given the previous closing price of $25.78, this indicates a potential upside of 0.85 percent. OLK stock price is now 33.73% away from the 50-day moving average and 29.92% away from the 200-day moving average. The market capitalization of the company currently stands at $3.19B.
A total of 4 analysts have issued a hold rating and 0 have given it a buy rating. Brokers who have rated the stock have averaged $26.00 as their price target over the next twelve months.
With the price target of $27, Scotiabank recently initiated with Sector Outperform rating for Olink Holding AB (publ) ADR (NASDAQ: OLK).
A total of 0.65% of the company’s stock is owned by insiders.
Thursday’s opening bell rang with an opening price of $25.78 for Olink Holding AB (publ) ADR (NASDAQ: OLK). During the past 12 months, Olink Holding AB (publ) ADR has had a low of $14.10 and a high of $26.47. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 7.41, and a quick ratio of 5.84. The fifty day moving average price for OLK is $19.31 and a two-hundred day moving average price translates $19.88 for the stock.
The latest earnings results from Olink Holding AB (publ) ADR (NASDAQ: OLK) was released for Jun, 2023. According to the Diagnostics & Research Company, earnings per share came in at -$0.01, beating analysts’ expectations of -$0.08 by 0.07. This compares to -$0.01 EPS in the same period last year. The net profit margin was -12.32% and return on equity was -4.09% for OLK. The company reported revenue of $44.15 million for the quarter, compared to $31.77 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 38.97 percent. For the current quarter, analysts expect OLK to generate $91.98M in revenue.
Olink Holding AB (publ) ADR(OLK) Company Profile
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company’s products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, the company provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden.